R. PLATT, M.D.; A. MUNOZ, Ph.D.; J. STELLA, R.N.; S. VanDEVANTER, M.D.; J. K. KOSTER Jr., M.D.
Two hundred twenty patients were randomly assigned to receive either ceforanide or cephalothin as perioperative antibiotic prophylaxis during cardiovascular surgery. More infections were seen among cephalothin recipients (8 deep, 32 total) than among ceforanide recipients (1 deep, 17 total). Among patients who had only coronary artery bypass grafting, more cephalothin recipients had infection than did ceforanide recipients (19 of 82 as opposed to 7 of 83;p=0.001; relative risk, 2.7; 95% confidence interval, 1.22 to 6.18). The difference between the two regimens was attributable to fewer blood, wound, and urinary tract infections. Among patients who had other procedures, there was no difference in the efficacy of the two regimens. Cephalothin recipients who developed wound or blood stream infections had lower antibiotic levels in their atrial appendages than recipients not developing such infections (p=0.02). If one assumes that cephalothin does not increase the risk of infection, then these data show that antibiotic prophylaxis prevents infection after coronary artery bypass surgery, and, in the dosages used, that ceforanide is superior to cephalothin.
Learn more about subscription options.
Register Now for a free account.
PLATT R, MUNOZ A, STELLA J, VanDEVANTER S, KOSTER JK. Antibiotic Prophylaxis for Cardiovascular Surgery: Efficacy with Coronary Artery Bypass. Ann Intern Med. 1984;101:770–774. doi: 10.7326/0003-4819-101-6-770
Download citation file:
Published: Ann Intern Med. 1984;101(6):770-774.
Cardiology, Coronary Heart Disease.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only